Pages that link to "Q79882008"
Jump to navigation
Jump to search
The following pages link to Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system (Q79882008):
Displaying 22 items.
- Improved dissolution and anti-inflammatory activity of ibuprofen-polyethylene glycol 8000 solid dispersion systems (Q28829654) (← links)
- Utility of physiologically based absorption modeling in implementing Quality by Design in drug development (Q30498061) (← links)
- Mechanistic approaches to predicting oral drug absorption (Q33432960) (← links)
- Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data (Q33442896) (← links)
- Practical anticipation of human efficacious doses and pharmacokinetics using in vitro and preclinical in vivo data (Q33496817) (← links)
- Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. (Q33986048) (← links)
- Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe (Q36137372) (← links)
- Drug absorption modeling as a tool to define the strategy in clinical formulation development (Q37254283) (← links)
- Understanding the effect of API properties on bioavailability through absorption modeling (Q37323446) (← links)
- Soft Gelatin Capsules (Softgels) (Q37782318) (← links)
- Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications (Q37925176) (← links)
- An update on computational oral absorption simulation (Q37937047) (← links)
- Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options (Q39041851) (← links)
- A Formulation Strategy for Gamma Secretase Inhibitor ELND006, a BCS Class II Compound: Development of a Nanosuspension Formulation with Improved Oral Bioavailability and Reduced Food Effects in Dogs (Q39418393) (← links)
- Bioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats (Q40492986) (← links)
- Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity (Q41987467) (← links)
- Phase behavior of amorphous molecular dispersions II: Role of hydrogen bonding in solid solubility and phase separation kinetics (Q46441779) (← links)
- Effect of polymer additives on the transformation of BMS-566394 anhydrate to the dihydrate form (Q57186494) (← links)
- Single-Step Preparation and Deagglomeration of Itraconazole Microflakes by Supercritical Antisolvent Method for Dissolution Enhancement (Q83462714) (← links)
- Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion (Q87666677) (← links)
- Solid Dispersion of Curcumin as Polymeric Films for Bioenhancement and Improved Therapy of Rheumatoid Arthritis (Q89335759) (← links)
- Aqueous Dissolution and Dispersion Behavior of Polyvinylpyrrolidone Vinyl Acetate-based Amorphous Solid Dispersion of Ritonavir Prepared by Hot-Melt Extrusion with and without Added Surfactants (Q98626014) (← links)